![Biggest blockbuster drugs of 2020 : Drug sales and beyond – Pharmaceutical Marketing and Strategies for Today Biggest blockbuster drugs of 2020 : Drug sales and beyond – Pharmaceutical Marketing and Strategies for Today](https://www.pharmadigicoach.com/wp-content/uploads/2021/09/Bristol-Myers-Squibb-BMS-pharma-Top-selling-drugs-2020.jpg)
Biggest blockbuster drugs of 2020 : Drug sales and beyond – Pharmaceutical Marketing and Strategies for Today
![17 of 20 top pharmaceutical companies be revenue reported YoY growth in 2019, says GlobalData - GlobalData 17 of 20 top pharmaceutical companies be revenue reported YoY growth in 2019, says GlobalData - GlobalData](https://www.globaldata.com/wp-content/uploads/2020/08/PR10402-1024x585.png)
17 of 20 top pharmaceutical companies be revenue reported YoY growth in 2019, says GlobalData - GlobalData
![Bristol-Myers Squibb (BMY): Strengthening Grip On Oncology, Cardiovascular Disease Drugs | Seeking Alpha Bristol-Myers Squibb (BMY): Strengthening Grip On Oncology, Cardiovascular Disease Drugs | Seeking Alpha](https://static.seekingalpha.com/uploads/2021/6/10/saupload_Im4BbFpK0j_vHfyMWr1pjXvY0TdCPIDm_E7EZ2roRgzEWTldBhgBwtS7BPCu0ZWaV40eoxDsnIxZkXmWmWZThkl5M6THHeYLSIPoyCpxIHfUiCpAn3V2mvGFPdbnzdM0fEXzY7kR.png)
Bristol-Myers Squibb (BMY): Strengthening Grip On Oncology, Cardiovascular Disease Drugs | Seeking Alpha
![Bristol-Myers Squibb's Opdivo secures a lung cancer niche with small-cell green light | Fierce Pharma Bristol-Myers Squibb's Opdivo secures a lung cancer niche with small-cell green light | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1534515255/FierceImages-Opdivo3.jpg/FierceImages-Opdivo3.jpg?VersionId=YC0PvIE7xyrfhP6eg3tyeoev9ybBDt3y)